Soligenix
SNGX
#11002
Rank
โ‚ฌ6.52 M
Marketcap
0,30ย โ‚ฌ
Share price
0.51%
Change (1 day)
-74.51%
Change (1 year)

Soligenix (SNGX) - Total liabilities

Total liabilities on the balance sheet as of March 2026 : โ‚ฌ3.43 Million

According to Soligenix's latest financial reports the company's total liabilities are โ‚ฌ3.43 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Soligenix - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2022-12-31โ‚ฌ15.61 M9.52%
2021-12-31โ‚ฌ14.25 M8.59%
2020-12-31โ‚ฌ13.12 M132.79%
2019-12-31โ‚ฌ5.64 M53.2%
2018-12-31โ‚ฌ3.68 M36.76%
2017-12-31โ‚ฌ2.69 M-1.34%
2016-12-31โ‚ฌ2.72 M-59.72%
2015-12-31โ‚ฌ6.77 M15.88%
2014-12-31โ‚ฌ5.84 M-19.57%
2013-12-31โ‚ฌ7.26 M732.94%
2012-12-31โ‚ฌ0.87 M-20.92%
2011-12-31โ‚ฌ1.1 M-23.21%
2010-12-31โ‚ฌ1.43 M70.08%
2009-12-31โ‚ฌ0.84 M-14.79%
2008-12-31โ‚ฌ0.99 M21.25%
2007-12-31โ‚ฌ0.81 M-57.12%
2006-12-31โ‚ฌ1.9 M22.43%
2005-12-31โ‚ฌ1.55 M1.35%
2004-12-31โ‚ฌ1.53 M92.03%
2003-12-31โ‚ฌ0.8 M-46.13%
2002-12-31โ‚ฌ1.48 M-90.41%
2001-12-31โ‚ฌ15.47 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
โ‚ฌ103.76 B 3,023,741.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚ฌ103.53 B 3,017,036.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚ฌ60.79 B 1,771,509.87%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
โ‚ฌ10.88 M 217.19%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚ฌ39.23 M 1,043.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚ฌ28.73 B 837,420.94%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
โ‚ฌ0.69 B 20,130.96%๐Ÿ‡บ๐Ÿ‡ธ USA